Prevention of Catheter-Associated Urinary Tract Infection in Incontinence and Reconstructive Pelvic Surgery Patients

Stopped early · Not applicable · Has a placebo group

Conditions studied: Catheter-Associated Urinary Tract Infection

In brief

The study will assess the risk of catheter associated urinary tract infection in women undergoing incontinence or reconstructive pelvic surgery. Women will be given an antibiotic or placebo at the time of catheter removal. The investigators hypothesize that prophylactic antibiotics will reduce the rate of infection.

Key facts

Study ID

NCT01108757

Run by

The Cleveland Clinic

People needed

52

Starts

2010-04-01

Expected to finish

2013-08-01

Last updated by the study team

2017-10-18

Who can join

Age: 21 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Requires catheterization >24h hours following incontinence or pelvic reconstructive surgery

You may not qualify if…

• Receipt of antibiotics for either prophylaxis or treatment of a known infection during the postoperative hospitalization
• Allergy to sulfonamides or trimethoprim
• Non-English speaking
• Pregnancy
• Breast feeding
• Severe renal impairment (creatinine clearance <30)
• Patients taking dofetilide, methenamine, procaine, warfarin, procainamide, methotrexate.

Where it is running

• Cleveland Clinic Foundation — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.